Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

56.34
Delayed Data
As of 4:02pm ET
 +0.05 / +0.09%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.00%
Year-to-Date

Stock Price Forecast

The 34 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 61.86, with a high estimate of 75.98 and a low estimate of 44.89. The median estimate represents a +9.79% increase from the last price of 56.34.

Analyst Recommendations

The current consensus among 34 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.58
Sales
$4.3B
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.75%
 
 
 
 
 
 
Growthannually 17.60%
 
 
 
 
 
 

Sales

Growthquarterly 1.67%
 
 
 
 
 
 
Growthannually 9.94%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.